Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: September 2012

RepliCel Life Sciences, Inc. (REPCF) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

RepliCel Life Sciences is a patented natural hair cell replication technology that has the potential to become the world’s first, minimally invasive solution for androgenetic alopecia and general hair loss in men and women. The company’s RepliCel™ is based on … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

AudioCodes Ltd. (AUDC) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

AudioCodes designs, develops and sells advanced Voice over IP (VoIP) and converged VoIP and data networking products and applications to service providers and enterprises. The company’s converged VoIP and data communications and products are deployed globally in broadband, mobile, enterprise … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Curis, Inc. (CRIS) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Curis is a drug development company focused on leveraging its signaling pathway drug technologies to seek to create new targeted small molecule drug candidates for cancer. The company develops the Erivedge (vismodegib) capsule, which is FDA-approved for the treatment of … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Newtek Business Services, Inc. (NEWT) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Newtek Business Services, The Small Business Authority, is a direct distributor of a wide range of business services and financial products to the small- and medium-sized business market under the Newtek® brand. The company provides tools designed to help its … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Provectus Pharmaceuticals, Inc. (PVCT) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Provectus Pharmaceuticals is engaged in the development of oncology and dermatology therapies with a focus is on melanoma, breast cancer and cancers of the liver. PVCT has received orphan drug designations from the FDA for its melanoma and hepatocellular carcinoma … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

VirtualScopics, Inc. (VSCP) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

VirtualScopics provides quantitative imaging solutions for the pharmaceutical, biotechnology and medical device industries. VSCP has developed a software platform for analysis and modeling of both structural and functional medical images. The company is focused on the therapeutic areas of expertise … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Neuralstem, Inc. (CUR) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Neuralstem is a biopharmaceutical company focused on the development and commercialization of treatments for central nervous system disease based on transplanting human neural stem cells and the use of small molecule drugs. CUR is in an FDA-approved phase 1 safety … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Bacterin International Holdings, Inc. (BONE) Reports Positive First Clinical Results for OsteoSponge SC Product

Bacterin International Holdings develops, manufactures, and markets biologics products, such as bone graft material and antimicrobial coatings, worldwide. The company’s proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone, subchondral … Continue reading

Posted in Small Cap News | Leave a comment

XZERES Corp. (XPWR) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

XZERES is a renewable energy and clean energy technology company that designs, develops, manufactures and markets distributed generation, wind power systems, as well as power management and power efficiency solutions for the commercial, light industrial and residential markets. XPWR’s grid … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Aeterna Zentaris, Inc. (AEZS) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

Aeterna Zentaris is an oncology and endocrinology drug development company with a pipeline that includes compounds at all stages of development, from drug discovery to marketed products. AEZS is currently investigating treatments for various unmet medical needs. The company’s portfolio … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment